John Ordell, a young scientist, moves to Washington, DC with the goal of working in biotechnology using the cutting-edge gene-editing innovation called crispr. He is transformed from a humble Ph.D. student to a trail-blazing entrepreneur, drawn into a scheme driven by greed, corporate espionage, high finance, and international intrigue. John, his enabling cohorts, and a […]